Statistically based survival rate estimation in patients with soft tissue tumors

Open access

Abstract

Although most soft tissue tumors are benign, with a high healing rate after surgical excision, there is a variety of malignant tumors with differences in progression and prognosis. The study aimed to assess the survival rate in patients diagnosed with this pathology, based on the patient’s characteristics (age, gender, race), as well as the tumor’s histological type, differentiation degree, location and size. The retrospective study included a group of 103 patients diagnosed during 2010 and 2017 in our department. Considering the high healing rate of benign tumors, only the group of neoplastic patients (45 cases) was involved in the survival rate estimation, assessing tumor characteristics and individual comorbidities. Within this lot, we emphasized a predominance of neoplasm in patients aged over 50 years (32 cases), men (29 cases), and localization of the neoplasm in the thigh (23 cases). The predominant histopathological type, liposarcoma, was diagnosed in 67% of the cases, with dimensions over 6 cm and with local extension. There have been significant variations in mortality between the different histological subtypes (liposarcoma vs. synovial sarcoma). Local recurrences were showed in 18 cases of liposarcoma in the first 2 years after the surgical excision, with an increased aggressiveness of this neoplasm in men over 50 years. 12 cases developed distant metastasis, and until the end of the study, 7 deaths were reported in 3 cases involving associated comorbidities. The five-year survival is inversely proportional to the extent of the tumor and the local invasion, as well as to the age of the patient. An overall survival rate is difficult to appreciate in the context of a heterogeneous group of tumors so it must be evaluated for every histological subtype taking into account the patient’s particularities.

1. Fletcher CDM, Unni KK, Mertens F. Pathology and genetics of tumours of soft tissue and bone. World Health Organization Classification of Tumours. 2002, Lyon, France: IARC Press, 9-175.

2. Beaman F, Jelinek J, Priebat D. Current imaging and therapy of malignant soft tissue tumors and tumor-like lesions. Semin Musculoskelet Radiol. 2013; 17(02):168-176.

3. Soft tissue sarcoma statistics. Cancer Research UK. http://www.cancerresearchuk.org/healthprofessional/cancer-statistics/statistics-bycancertype/soft-tissue-sarcoma#heading-Zero.

4. Jemal A, Tiwari RC, Murray T et al. Cancer statistics 2004. CA Cancer J Clin. 2004; 54:8-29.

5. Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis 1. Am J Epidemiol. 2000; 151(1):33-40.

6. Chen CS, Suthers G, Carroll J, Rudzki Z, Muecke J. Sarcoma and familial retinoblastoma. Clin Exp Ophthal. 2003; 31(5):392-6.

7. Bell DW, Varley JM, Szydlo TE, Kanf DH, Wahrer DC, Shannon KE, Lubratovich M, Verselis SJ, Isselbacher KJ, Fraumeni JF et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. Science. 1999; 286(5449):2528-31.

8. http://www.lifemath.net/cancer/sarcoma/outcome/index.php.

9. Fletcher CDM, Bridge JA, Hogendoom P, Mertens F. WHO Classification of soft tissue tumors, Volume 5: WHO Classification of Soft Tissue and Bone, 4th ed., 2013, Geneva: WHO Press.

10. Costa J, Wesley RA, Glatstein E, Rosenberg SA. The grading of soft tissue sarcomas. Results of a clinico histopathologic correlation in a series of 163 cases.

11. Enneking WF. Staging of musculoskeletal tumors. In: Enneking WF. Musculoskeletal Tumor Surgery, vol. 1, 1983, New York: Churchill Livingstone, 87-8.

12. http://cancerstaging.org/references-tools/Pages/What-is-Cancer-Staging.aspx.

13. Knapp EL, Kransdorf MJ, Letson GD. Diagnostic imaging update: soft tissue sarcomas. Cancer Control. 2005; 12(1):22-26.

14. Bancroft L, Pettis C, Wasyliw C. Imaging of benign soft tissue tumors. Semin Musculoskelet Radiol. 2013; 17(02):156-167.

15. Smith S, Salanitri J, Lisle D. Ultrasound evaluation of soft tissue masses and fluid collections. Semin Musculoskelet Radiol. 2007; 11(2):174-191.

16. Downes KA, Goldblum JR, Montgomery EA et al. Pleomorphic liposarcoma: a clinicopathologic analysis of 19 cases. Mod Pathol. 2001; 14:179-184.

17. Kooby DA, Antonescu CR, Brennan MF et al. Atypical lipomatous tumor/ well-differentiated liposarcoma of the extremity and trunk wall: importance of histological subtype with treatment recommendations. Ann Surg Oncol. 2004; 11(1):78-84. 10.1007/BF02524350.

18. Rom J Morphol Embryol. 2015; 56(1):169-73.

19. Zagars GK, Ballo MT, Pisters PW et al. Prognostic factors for patients with localized soft tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1225 patients. Cancer. 2003; 97:2530-2543.

20. Grobmyer SR, Brennan MF. Predictive variables detailing the recurrence rate of soft tissue sarcomas. Curr Opin Oncol. 2003; 15(4):319-26.

Romanian Journal of Orthopaedic Surgery and Traumatology

Official publication of Societatea Română de Oncologie Musculo-Scheletală and Societatea Română de Artroplastie

Journal Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 51 51 17
PDF Downloads 33 33 7